AlphaQuest’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-526
Closed -$51.2K 1004
2025
Q4
$51.2K Sell
526
-825
-61% -$70.8K ﹤0.01% 1936
2025
Q3
$96.1K Sell
1,351
-1,657
-55% -$110K 0.01% 1744
2025
Q2
$180K Sell
3,008
-4,230
-58% -$232K 0.02% 1193
2025
Q1
$380K Buy
7,238
+3,936
+119% +$221K 0.04% 657
2024
Q4
$182K Sell
3,302
-9,769
-75% -$514K 0.02% 896
2024
Q3
$657K Buy
13,071
+3,236
+33% +$149K 0.06% 545
2024
Q2
$432K Buy
9,835
+7,950
+422% +$338K 0.06% 507
2024
Q1
$82.9K Buy
+1,885
New +$83.3K 0.01% 854

Other funds holding IRMD

AlphaQuest's IRMD Position: Q1 2026 in Review

AlphaQuest sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 526 shares — an estimated $51.2K sold.

AlphaQuest first reported a position in IRMD in Q1 2024 and held it in 8 quarters. The position peaked at $657K in Q3 2024. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • AlphaQuest reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 526 iRadimed shares in Q1 2026, an estimated $51.2K.
  • AlphaQuest first reported a position in iRadimed in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's iRadimed position peaked at $657K in Q3 2024.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.